Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Craig Jordan

Showing results (211-220 of 218) with videos related to

Pageof 22
Sort By:
You have reached the last page of results.This site can display upto 218 results.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2011
Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across timeEric A Ariazi, Heather E Cunliffe, Joan S Lewis-Wambi, et al.
The Journal of Biological Chemistry|January 18, 2005
The small heat shock protein alpha B-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3Merideth C Kamradt, Meiling Lu, Michael E Werner, et al.
Molecular Cancer Therapeutics|November 12, 2020
Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast CancerBalkees Abderrahman, Philipp Y Maximov, Ramona F Curpan, et al.
Molecular Pharmacology|May 5, 2020
The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer CellsPhilipp Y Maximov, Balkees Abderrahman, Yousef M Hawsawi, et al.
Molecular Cancer Therapeutics|November 9, 2007
Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgenEric A Ariazi, Andrei Leitão, Tudor I Oprea, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 21, 2010
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancerVictor G Vogel, Joseph P Costantino, D Lawrence Wickerham, et al.
JAMA|June 7, 2006
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trialVictor G Vogel, Joseph P Costantino, D Lawrence Wickerham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forwardGary J Kelloff, Scott M Lippman, Andrew J Dannenberg, et al.
Pageof 22

Showing results (211-220 of 218) with videos related to

Sort By:
Pageof 22
You have reached the last page of results.This site can display upto 218 results.
Proceedings of the National Academy of Sciences of the United States of America|October 21, 2011
Estrogen induces apoptosis in estrogen deprivation-resistant breast cancer through stress responses as identified by global gene expression across timeEric A Ariazi, Heather E Cunliffe, Joan S Lewis-Wambi, et al.
The Journal of Biological Chemistry|January 18, 2005
The small heat shock protein alpha B-crystallin is a novel inhibitor of TRAIL-induced apoptosis that suppresses the activation of caspase-3Merideth C Kamradt, Meiling Lu, Michael E Werner, et al.
Molecular Cancer Therapeutics|November 12, 2020
Rapid Induction of the Unfolded Protein Response and Apoptosis by Estrogen Mimic TTC-352 for the Treatment of Endocrine-Resistant Breast CancerBalkees Abderrahman, Philipp Y Maximov, Ramona F Curpan, et al.
Molecular Pharmacology|May 5, 2020
The Structure-Function Relationship of Angular Estrogens and Estrogen Receptor Alpha to Initiate Estrogen-Induced Apoptosis in Breast Cancer CellsPhilipp Y Maximov, Balkees Abderrahman, Yousef M Hawsawi, et al.
Molecular Cancer Therapeutics|November 9, 2007
Exemestane's 17-hydroxylated metabolite exerts biological effects as an androgenEric A Ariazi, Andrei Leitão, Tudor I Oprea, et al.
Cancer Prevention Research (Philadelphia, Pa.)|April 21, 2010
Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancerVictor G Vogel, Joseph P Costantino, D Lawrence Wickerham, et al.
JAMA|June 7, 2006
Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trialVictor G Vogel, Joseph P Costantino, D Lawrence Wickerham, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 17, 2006
Progress in chemoprevention drug development: the promise of molecular biomarkers for prevention of intraepithelial neoplasia and cancer--a plan to move forwardGary J Kelloff, Scott M Lippman, Andrew J Dannenberg, et al.
Pageof 22